Synergistic activity of the MCL-1 inhibitor S63845 with midostaurin in preclinical human models of FLT3-ITD mutated acute myeloid leukemia (AML)
This applies well to those with vitamin B12 deficiency
Patients should avoid applying the product around the eyes, consume plenty of water, avoid late meals, engage in light exercises, and refrain from sauna visits for the first 2 to 3 days after treatment
At minimum, document: Date, time, and dose of each administration Injection site rotation schedule Batch and lot number of peptide used for each administration Storage temperature logs (daily minimum and maximum) Reconstitution dates and volumes for each vial Subjective observations (appetite changes, energy levels, GI effects) Objective measurements on a defined schedule (weekly, biweekly, or monthly depending on parameter) Good documentation transforms anecdotal experience into usable data
Danone is prioritizing research and product development to better understand the role of protein and the nutritional needs of GLP-1 users